Cross Country Healthcare to be Acquired by Knox Lane for $437 Million in All-Cash Deal
summarizeSummary
Cross Country Healthcare has entered into a definitive agreement to be acquired by Knox Lane for $13.25 per share in an all-cash transaction valued at $437 million, representing a significant premium.
check_boxKey Events
-
Definitive Merger Agreement Signed
Cross Country Healthcare, Inc. has entered into a definitive Agreement and Plan of Merger to be acquired by KL Criss Cross Intermediate, LLC, an affiliate of Knox Lane LP.
-
All-Cash Acquisition Price
Each outstanding share of common stock will be converted into the right to receive $13.25 in cash, without interest.
-
Total Transaction Value
The all-cash transaction is valued at $437 million, representing a significant premium to the company's recent trading prices.
-
Post-Acquisition Status
Upon completion, Cross Country Healthcare will become a privately held platform company in Knox Lane's portfolio and will cease trading on Nasdaq.
auto_awesomeAnalysis
This 8-K filing details the definitive merger agreement for Cross Country Healthcare to be acquired by Knox Lane for $13.25 per share in cash, valuing the company at $437 million. This represents a substantial premium to recent trading prices. The acquisition, if completed, will result in the company becoming privately held and its shares delisted. This filing follows a DEFA14A and news reports announcing the acquisition, providing the full legal terms and conditions. The cancellation of the upcoming Q1 earnings call and annual meeting are direct consequences of the pending merger. Investors should monitor regulatory approvals and the shareholder vote.
At the time of this filing, CCRN was trading at $12.94 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $326.7M. The 52-week trading range was $7.43 to $14.99. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.